Two dimensional protein patterns of bronchoalveolar lavage fluid from non-smokers, smokers, and subjects exposed to asbestos

Thorax

Volumn 51, Issue 10, 1996, Pages 1028-1035

  Lindahl, Mats ^a   Ekström, Tommy ^a   Sörensen, Jan ^a   Tagesson, Christer ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Asbestos; Bronchoalveolar lavage fluid; Two dimensional gel electrophoresis

Indexed keywords

ASBESTOS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GEL ELECTROPHORESIS; HUMAN; LUNG; LUNG LAVAGE; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SMOKING;

EID: 0029804716     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.10.1028     Document Type: Article

References (30)

1. Robinson DS, Bentley AM, Hartnell A, Kay AB, Durham SR. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax 1993;48:26-32.
2. Bjermer L, Eklund A, Blaschke E. Bronchoalveolar lavage fibronectin in patients with sarcoidosis: correlation to hyaluronan and disease activity. Eur Respir J 1991;4:965-71.
3. 2 in patients with septic shock and trauma. Intensive Care Med 1994;20:555-61.
4. Turner-Warwick ME, Haslam PL. Clinical applications of bronchoalveolar lavage: an interim view. Br J Chest 1986;80:105-21.
5. Henderson RF. Use of bronchoalveolar lavage to detect lung damage. In: Gardner DE, Crapo JD, Massaro EJ, eds. Toxicology of the lung. New York: Raven Press, 1988:239-68.
6. Barbers RG, Abraham JL. Asbestosis occurring after brief inhalational exposure: usefulness of bronchoalveolar lavage in diagnosis. Br J Ind Med 1989;46:106-10.
7. O'Farrell PH. High resolution two dimensional gel electrophoresis of proteins. J Biol Chem 1975;250:4007-21.
8. Anderson L, Anderson N. Some perspectives on two-dimensional protein mapping. Clin Chem 1984;30:1898-905.
9. Dunn MJ. Two-dimensional gel electrophoresis of proteins. J Chromatogr 1987;418:145-85.
10. Hader D-P, Kauer G. Image analysis techniques for automatic evaluation of two-dimensional electrophoresis. Electrophoresis 1990;11:407-15.
11. Lindahl M, Stahlbom B, Tagesson C. Two-dimensional gel electrophoresis of nasal and bronchoalveolar lavage fluids after occupational exposures. Electrophoresis 1995; 16:1199-204.
12. Lenz A-G, Meyer B, Costabel U, Maier K. Bronchoalveolar lavage fluid proteins in human lung disease: analysis by two-dimensional electrophoresis. Electrophoresis 1993; 14:242-4.
13. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 1976; 72:248-52.
14. Celis JE, Bravo R. Two-dimensional gel electrophoresis of proteins. Orlando:Academic Press, 1984.
15. 2 from rat lung with affinity chromatography and two-dimensional gel electrophoresis. Biochim Biophys Acta 1989;1005:282-8.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
17. Switzer RC III, Merril CR, Shifrin SA. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem 1979;98:231-7.
18. Oakley BR, Kirsch DR, Morris NR. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 1980;105:361-3.
19. Pepinsky RB, Sinclair LK, Dougas I, Liang C-M, Lawton P, Browning JE. Monoclonal antibodies to lipocortin-1 as probes for biological function. FEBS Lett 1990;261:247-52.
20. Ambrose MP, Hunninghake GW. Corticosteroids increase lipocortin 1 in BAL fluid from normal individuals and patients with lung disease. J Appl Physiol 1990;68:1668-71.
21. Smith SF, Tetley TD, Guz A, Flower RJ. Detection of lipocortin 1 in human lung lavage fluid: lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation. Environ Health Perspect 1990;85:135-44.
22. Bell DY, Haseman JA, Spock A, McLennan G, Hook GER. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am Rev Respir Dis 1981;124:72-8.
23. Burke WMJ, Roberts CM, Bryant DH, Cairns D, Yeates M, Morgan GW, et al. Smoking-induced changes in epithelial lining fluid volume cell density and protein. Eur Respir J 1992;5:780-4.
24. Ljungman AG, Lindahl M, Tagesson C. Asbestos fibres and man made mineral fibres: induction release of tumour necrosis factor-α from rat alveolar macrophages. Occup Environ Med 1994;51:777-83.
25. Schwartz DA, Galvin JR, Frees KL, Dayton CS, Burmeister LF, Merchant JA, et al. Clinical relevance of cellular mediators of inflammation in workers exposed to asbestos. Am Rev Respir Dis 1993;148:68-74.
26. Lindahl M, Hede AR, Tagesson C. Lysophosphatidylcholine increases airway and capillary permeability in the isolated perfused rat lung. Exp Lung Res 1986;11:1-12.
27. Persson CGA. Plasma exudation in tracheobronchial and nasal airways: a mucosal defence mechanism becomes pathogenic in asthma and rhinitis. Eur Respir J 1990; 3:652-7s.
28. Morgan EH. Transferrin. In: Haeberli A, ed. Human protein data. Weinheim: VCH, 1st instalment, 1992.
29. Cullen MR, Merrill WW. Association between neutrophil concentration in bronchoalveolar lavage fluid and recent losses in diffusing capacity in men formerly exposed to asbestos. Chest 1992;102:682-7.
30. Dunn MJ, ed. 2D electrophoresis: from protein maps to genomes. Electrophoresis 1995;16:1077-326.